Theravance Biopharma, Inc. Other Long-term Investments
Theravance Biopharma, Inc. (TBPH) had Other Long-term Investments of $0 as of 2017-12-31, per its 10-K filed 2018-02-28.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Long-Term Investments
us-gaap:OtherLongTermInvestments · last filed 2018-02-28
- 2017-12-31: Other Long-term Investments $0.00.
- 2017-09-30: Other Long-term Investments $0.00.
- 2017-06-30: Other Long-term Investments $8.00M.
- 2017-03-31: Other Long-term Investments $8.00M.
| Period end | Other Long-term Investments |
|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-02-28 |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-08 |
| 2017-06-30 | $8.00M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $8.00M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $8.00M 10-K · filed 2018-02-28 |
| 2016-09-30 | $8.00M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $8.00M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $8.00M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $8.00M 10-K · filed 2017-03-01 |
| 2015-09-30 | $8.00M 10-Q · filed 2015-11-12 |
| 2014-12-31 | $0.00 10-K · filed 2016-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |